Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Proteolytic System”

522 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 522 results

Large-scale testing (Phase 3)Study completedNCT00242840
What this trial is testing

Observational Study Of A Protease Inhibitor (PI) Containing Regimen In Subjects With PI Mutations Selected During Prior Treatment With GW433908 (Fosamprenavir)

Who this might be right for
Infection, Human Immunodeficiency Virus IHIV Infection
ViiV Healthcare 20
Large-scale testing (Phase 3)Ended earlyNCT02710266
What this trial is testing

Evaluation of the Effect of Gabexate Mesilate in the Hepatocyte Protection After Liver Resection

Who this might be right for
Liver Disease
Yonsei University 2
Post-approval studies (Phase 4)UnknownNCT00699322
What this trial is testing

Effect of Dipeptidyl Peptidase-IV Inhibitor and Sulfonylurea on Glucose Variability and Oxidative Stress

Who this might be right for
Type 2 Diabetes
The Catholic University of Korea 36
Not applicableStudy completedNCT00000892
What this trial is testing

Several Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Used Indinavir

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 300
Large-scale testing (Phase 3)Study completedNCT01448707
What this trial is testing

A Clinical Trial Comparing the Efficacy of Darunavir/Ritonavir Monotherapy Versus a Triple Combination Therapy Containing Darunavir/Ritonavir and 2 Nucleoside/Nucleotide Reverse Transcriptase Inhibitors in Patients With Undetectable Plasma HIV-1 RNA on Current Treatment

Who this might be right for
Human Immunodeficiency Virus (HIV) InfectionsAcquired Immunodeficiency Syndrome (AIDS) Virus
Janssen-Cilag International NV 274
Early research (Phase 1)Study completedNCT00866853
What this trial is testing

TMC435-TiDP16-C107: This Study Measures the (Possible) Influence of TMC435 on the Activity of a Selected Set of Drug-degrading Proteins by Measuring the Blood Levels of Drugs That Have Been Taken Together With TMC435 and That Are Known to be Specifically Degraded by These Drug-degrading Proteins.

Who this might be right for
Hepatitis CViruses
Tibotec Pharmaceuticals, Ireland 16
Testing effectiveness (Phase 2)Study completedNCT00002423
What this trial is testing

Compare Two Anti-HIV Drug Combinations That Include Amprenavir in HIV-Infected Patients Who Have Failed Anti-HIV Drug Combinations That Did Not Include Amprenavir

Who this might be right for
HIV Infections
Glaxo Wellcome 100
Testing effectiveness (Phase 2)UnknownNCT03967925
What this trial is testing

Rituximab and Belimumab Combination Therapy in PR3 Vasculitis

Who this might be right for
ANCA Associated VasculitisGranulomatosis With Polyangiitis
Rachel Jones 31
Testing effectiveness (Phase 2)WithdrawnNCT00029250
What this trial is testing

Garlic in Hyperlipidemia Caused by HAART

Who this might be right for
HIV InfectionsHypercholesterolemiaHypertriglyceridemia+1 more
National Center for Complementary and Integrative Health (NCCIH)
Testing effectiveness (Phase 2)Study completedNCT00000885
What this trial is testing

Treatment Success and Failure in HIV-Infected Subjects Receiving Indinavir in Combination With Nucleoside Analogs: A Rollover Study for ACTG 320

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 440
Testing effectiveness (Phase 2)Study completedNCT00002185
What this trial is testing

A Pilot, Open-Label, Phase II, Randomized Study to Determine the Effects of Viracept on the Outcome of Cutaneous and Mucosal KS in AIDS Patients With CD4 <= 500 Cells/mm3

Who this might be right for
Sarcoma, KaposiHIV Infections
Agouron Pharmaceuticals 20
Testing effectiveness (Phase 2)Ended earlyNCT02239835
What this trial is testing

Tipranavir and Ritonavir vs. Saquinavir and Ritonavir Used With Two Nucleoside Reverse Transcriptase Inhibitors in Single Protease Inhibitor-experienced HIV-1 Patients

Who this might be right for
HIV Infections
Boehringer Ingelheim 79
Not applicableLooking for participantsNCT00187512
What this trial is testing

SCOPE: Observational Study of the Consequences of the Protease Inhibitor Era

Who this might be right for
HIV Infections
University of California, San Francisco 2,500
Post-approval studies (Phase 4)Study completedNCT00626301
What this trial is testing

Lopinavir/Ritonavir Monotherapy in Children

Who this might be right for
HIV Infections
The HIV Netherlands Australia Thailand Research Collaboration 40
Post-approval studies (Phase 4)Study completedNCT02406443
What this trial is testing

The INDORSE Study: Inhibition of Dipeptidyl Peptidase IV: Outcomes on Renal Sodium Excretion

Who this might be right for
Type 2 Diabetes
University Health Network, Toronto 36
Testing effectiveness (Phase 2)Study completedNCT00963885
What this trial is testing

RO5190591 (Danoprevir) in Combination With Pegasys and Copegus in Treatment-Naive Patients With Chronic Hepatitis C Genotype 1 Virus Infection

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 229
Large-scale testing (Phase 3)Study completedNCT00968708
What this trial is testing

Cardiovascular Outcomes Study of Alogliptin in Patients With Type 2 Diabetes and Acute Coronary Syndrome

Who this might be right for
Diabetes Mellitus, Type 2Acute Coronary Syndrome
Takeda 5,380
Post-approval studies (Phase 4)Study completedNCT00724711
What this trial is testing

Safety and Efficacy Study of Switching From Epzicom to Truvada

Who this might be right for
HIV Infection
Gilead Sciences 312
Early research (Phase 1)Study completedNCT00135434
What this trial is testing

Effect of HIV Protease Inhibitor Drugs on Glucose and Insulin Metabolism

Who this might be right for
HIV Infections
Bristol-Myers Squibb 25
Not applicableStudy completedNCT00001142
What this trial is testing

Metabolism and Body Shape of Healthy Children and Children With Chronic Infections

Who this might be right for
HIV InfectionsHealthyHyperlipidemia+1 more
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 185
Next Page